A 39-year-old man was admitted to our hospital with a 10-month history of shortness of breath and chest distress on exertion. Echocardiography showed a pericardial mass and effusion. Computed tomography (CT) (Picture A, B) demonstrated a thickened pericardium, effusion and a large pericardial mass (arrows) encompassing the left pulmonary artery compressing the left and right pulmonary arteries (Picture C). A positron emission tomography (PET) scan was positive along the pericardium. A pericardial biopsy using video-assisted thoracic surgery confirmed a diagnosis of sarcomatoid malignant mesothelioma (Picture D, Hematoxylin and Eosin staining, ×20). Immunohistochemical staining for calretinin, vimentin and CD34 was positive, while staining for EMA, SMA, desmin and S100 protein was negative. Owing to the sensitive location and poor prognosis of the tumor, the patient received no radiation treatment or chemotherapy. During follow-up, the symptoms of cough and shortness of breath worsened, and repeated CT revealed tumor progression. The patient died of cardiac failure 11 months after the diagnosis was made. Primary malignant pericardial mesothelioma (PMPM) is extremely rare, with an incidence of 0.0022% in an autopsy series of 500,000 case
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